Host Mike Moore sits down with Shri Rhagunathan, President & CEO of Noctrix Health.  Noctrix has the developed the only FDA approved device to Restless Legs Syndrome (RLS).  This disease affects 1 in 10 Americans, and is the 2nd most common sleep disorder in the U.S.  A limited number of pharmaceutical options currently exist to treat this disease state, all of which have a  number of associated negative side effects.  Their Nidra devices is a paradigm shifting breakthrough in a heavily under treated patient population.

Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health